DeepMed Research

Northwestern University Human Resources

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1851-01-28

Employees: 5K

Market Cap: -

Website: https://www.venturecat.northwestern.edu

Clinical Trials

The Effects of Metreleptin in Congenital Leptin Deficiency

Completed

Conditions: Congenital Leptin Deficiency (Disorder)

First Posted Date: 2019-08-21

Last Posted Date: 2021-12-30

Lead Sponsor: Northwestern University

Target Recruit Count: 2

Registration Number: NCT04063488

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

A Research Study for Latina Women Undergoing Breast Cancer Treatment

Not Applicable

Completed

Conditions: Cancer-related Problem/Condition
Quality of Life
Stress, Emotional

Interventions: Behavioral: My Guide

First Posted Date: 2019-08-21

Last Posted Date: 2022-11-09

Lead Sponsor: Northwestern University

Target Recruit Count: 51

Registration Number: NCT04064151

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Positive Emotions After Acute Coronary Events at Northwestern University

Not Applicable

Terminated

Conditions: ACS - Acute Coronary Syndrome

Interventions: Behavioral: Positive Psychology + Motivational Interviewing

First Posted Date: 2019-08-20

Last Posted Date: 2022-12-01

Lead Sponsor: Northwestern University

Target Recruit Count: 1

Registration Number: NCT04062383

Locations: 🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

ENhanced Recovery in CHildren Undergoing Surgery

Phase 3

Recruiting

Conditions: Ulcerative Colitis
Crohn's Disease
Inflammatory Bowel Disease

Interventions: Procedure: Perioperative surgical care

First Posted Date: 2019-08-19

Last Posted Date: 2024-01-05

Lead Sponsor: Northwestern University

Target Recruit Count: 1260

Registration Number: NCT04060303

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Weekly Steroids in Muscular Dystrophy

Phase 2

Completed

Conditions: Limb-girdle Muscular Dystrophy
Becker Muscular Dystrophy

Interventions: Drug: Prednisone

First Posted Date: 2019-08-13

Last Posted Date: 2023-09-21

Lead Sponsor: Northwestern University

Target Recruit Count: 20

Registration Number: NCT04054375

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer

Early Phase 1

Conditions: Endometrial Endometrioid Adenocarcinoma

Interventions: Drug: Abemaciclib
Drug: Letrozole
Procedure: Therapeutic Conventional Surgery

First Posted Date: 2019-08-08

Last Posted Date: 2021-05-03

Lead Sponsor: Northwestern University

Target Recruit Count: 27

Registration Number: NCT04049227

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
🇺🇸
Northwestern University, Chicago, Illinois, United States

Nivolumab, BMS-986205, and Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma

Phase 1

Active, not recruiting

Conditions: Glioblastoma

Interventions: Drug: IDO1 Inhibitor BMS-986205 25mg
Drug: Nivolumab
Radiation: Radiation Therapy
Drug: IDO1 Inhibitor BMS-986205 100 mg
Drug: IDO1 Inhibitor BMS-986205 50 mg
Drug: Temozolomide

First Posted Date: 2019-08-07

Last Posted Date: 2024-08-15

Lead Sponsor: Northwestern University

Target Recruit Count: 18

Registration Number: NCT04047706

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

IntelliCare in College Students

Not Applicable

Completed

Conditions: Depression
Anxiety

Interventions: Behavioral: Mobile self-help intervention

First Posted Date: 2019-07-29

Last Posted Date: 2020-10-08

Lead Sponsor: Northwestern University

Target Recruit Count: 20

Registration Number: NCT04035577

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States

sEphB4-HSA in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 2

Conditions: Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents
Stage IVB Prostate Cancer AJCC v8
Prostate Carcinoma Metastatic in the Soft Tissue
PSA Progression
Testosterone Less Than 50 ng/dL
Castration Levels of Testosterone
Prostate Carcinoma Metastatic in the Bone
Metastatic Prostate Adenocarcinoma
Castration-Resistant Prostate Carcinoma
Progressive Disease

Interventions: Biological: Recombinant EphB4-HSA Fusion Protein

First Posted Date: 2019-07-26

Last Posted Date: 2022-04-27

Lead Sponsor: Northwestern University

Target Recruit Count: 14

Registration Number: NCT04033432

Locations: 🇺🇸
Northwestern University, Chicago, Illinois, United States
🇺🇸
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

fMRI Study of tES in Major Depression

Early Phase 1

Completed

Conditions: Depression

Interventions: Device: Transcranial Electrical Stimulation (tES)

First Posted Date: 2019-07-24

Last Posted Date: 2023-02-09

Lead Sponsor: Northwestern University

Target Recruit Count: 11

Registration Number: NCT04031547

Locations: 🇺🇸
Center for Translational Imaging at Northwestern University, Chicago, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy